Physician

Nathan R Littlejohn, M.D.

According to 2025 Medicare claims, Nathan Littlejohn, M.D. (NPI: 1215370861) practices urology in the Hot Springs, AR market, with the plurality of this provider's patient population coming from Garland, AR. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 71913-6457. Littlejohn is affiliated with the Baptist Health/UAMS Accountable Care Alliance (ACO ID: A3633) and AdvantagePoint Health Alliance - Hot Springs, LLC (ACO ID: A5037), participating under the MSSP model.

Littlejohn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 841 traditional Medicare patients, billed 7,656 HCPCS/CPT codes, and received $263,218 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,250 prescription claims across 765 beneficiaries totaling $218,212 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 97 claims. Open Payments data shows 61 records totaling $1,410. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,854 to $218,212. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	359	1,679	$100,912
2019	896	7,320	$309,282
2020	775	8,458	$289,873
2021	993	12,974	$414,089
2022	836	10,974	$331,090
2023	934	7,540	$281,180
2024	841	7,656	$263,218

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	152	$2,854
2016	25	58	$1,612
2017	N/R	N/R	N/R
2018	152	357	$18,092
2019	481	1,846	$119,394
2020	514	2,026	$144,999
2021	689	2,494	$176,420
2022	674	2,455	$194,711
2023	728	2,368	$206,029
2024	765	2,250	$218,212

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	11	87	$12,136
2021	14	84	$32,169
2022	19	126	$35,859
2023	13	90	$43,282
2024	14	97	$56,024

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	216	262	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	427	654	$84
36415	Insertion of needle into vein for collection of blood sample	209	263	$9
51798	Ultrasound measurement of bladder capacity after voiding	462	653	$6
81002	Urinalysis, manual test	536	783	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	108	4,193	$65,548
Orgovyx	Relugolix	24	718	$62,464
Gemtesa	Vibegron	85	2,978	$47,695
Tamsulosin Hcl	Tamsulosin Hcl	546	34,243	$5,701
Methenamine Hippurate	Methenamine Hippurate	93	2,950	$5,074

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	29	$35,471
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	14	68	$20,553

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	61	$1,410	COLOPLAST CORP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathan R. Littlejohn, M.D.?

Tedicare shows public-source Medicare data for Nathan R. Littlejohn, M.D. (NPI 1215370861), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathan R. Littlejohn, M.D. have ACO affiliation data?

Nathan R. Littlejohn, M.D. is shown with ACO affiliation data for Baptist Health/UAMS Accountable Care Alliance (MSSP, ACO ID A3633) and AdvantagePoint Health Alliance - Hot Springs, LLC (MSSP, ACO ID A5037).

What billing organization is linked to Nathan R. Littlejohn, M.D.?

Nathan R. Littlejohn, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Nathan R. Littlejohn, M.D. have Open Payments data?

Nathan R. Littlejohn, M.D. has 61 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.